Breakthroughs in RNA editing and radioligand therapies are poised to take biotech into a new era – driving innovation, growth and new investment opportunities Biotechnology is entering a dynamic new ...

Enfortumab vedotin plus pembrolizumab improved EFS, OS, and pCR rates in MIBC patients ineligible for cisplatin-based chemotherapy. The combination therapy showed a median EFS and OS that were not ...

With the lupus treatment landscape poised for a shake-up, Roche is hitting t | Early Monday, Roche announced that the FDA ...

The U.S. Supreme Court declined on Monday to hear a bid by a group of physicians and healthcare providers to revive their ...

This model, combining technology, trusted partners, and personalized engagement, offers a blueprint for a prevention-first ...

The latest update is out from GlaxoSmithKline ( (GB:GSK) ).

GSK may be happy with the latest readouts from two Hansoh-partnered antibody-drug conjugates, but the Big Pharma’s oncology R ...

The Catawba County Public Health Community Health Workers program is dedicated to ensuring that all families in Catawba ...

The U.S. FDA named the first nine recipients of the recently unveiled commissioner’s national priority voucher (CNPV) program aimed at addressing unmet public health needs by shortening regulatory ...

AstraZeneca (AZN) stock and GSK (GSK) stock gain as the U.K. and U.S. are reportedly clining in on a major drug pricing deal. Read more here.

NICE recommends ViiV Healthcare's Apretude as the first injectable PrEP for HIV prevention, offering an alternative to daily ...

By combining advanced automation with deep scientific expertise, Syngene has built a robust, end-to-end platform that connects discovery to downstream development and manufacturing, strengthening its ...